Last reviewed · How we verify

Colgate® Regular Cavity Protection

Johnson & Johnson Consumer and Personal Products Worldwide · FDA-approved active Small molecule Quality 2/100

Colgate® Regular Cavity Protection is a Small molecule drug developed by Johnson & Johnson Consumer and Personal Products Worldwide. It is currently FDA-approved.

At a glance

Generic nameColgate® Regular Cavity Protection
SponsorJohnson & Johnson Consumer and Personal Products Worldwide
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Colgate® Regular Cavity Protection

What is Colgate® Regular Cavity Protection?

Colgate® Regular Cavity Protection is a Small molecule drug developed by Johnson & Johnson Consumer and Personal Products Worldwide.

Who makes Colgate® Regular Cavity Protection?

Colgate® Regular Cavity Protection is developed and marketed by Johnson & Johnson Consumer and Personal Products Worldwide (see full Johnson & Johnson Consumer and Personal Products Worldwide pipeline at /company/johnson-johnson-consumer-and-personal-products-worldwide).

What development phase is Colgate® Regular Cavity Protection in?

Colgate® Regular Cavity Protection is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing